COMP <GO>
DRIO vs NEPH // ENTERPRISE SCALE & MARKET CAP
DarioHealth Corp. (NASDAQ) VS. Nephros Inc. (NASDAQ) • 15-METRIC TALLY: DRIO 0
— NEPH 7
▲ ENTERPRISE SCALE & MARKET CAP LEADER: NEPH
LAST: $3.31 (-2.93%) • MKT CAP: $32.4M
market-cap
$32.4M
LAST: $3.27 (+3.16%) • MKT CAP: $35.5M
market-cap
$35.5M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DRIO VS. NEPH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DRIO | NEPH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 56.60% | 61.90% | -5.30 | NEPH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 18.90% | -53.90 | NEPH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 26.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 4.50% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | 6.10% | -66.10 | NEPH | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 6.40% | -66.40 | NEPH | /net-margins <GO> |
| Revenue Growth (YoY) | — | 32.70% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | NEPH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 23.3 | 36.7 | -13.42 | NEPH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 25.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $32.4M | $35.5M | -$3.1M | NEPH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DRIO REV | NEPH REV | DRIO GROSS % | NEPH GROSS % | DRIO FCF | NEPH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $22.4M | $18.8M | 56.6% | 61.9% | -$26.1M | $1.6M |
| FY 2024 | $27.0M | $14.2M | 49.1% | 61.6% | -$38.7M | -$547.0K |
| FY 2023 | $0 | $14.2M | — | — | -$30.4M | $827.0K |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DRIO // BETA —
NEPH // BETA —